Safety and efficacy of a new oral contraceptive containing drospirenone
Shulman, L.P.
Journal of Reproductive Medicine 47(11 Suppl): 981-984
2002
ISSN/ISBN: 0024-7758 PMID: 12497672 Document Number: 246290
An oral contraceptive containing ethinyl estradiol and the unique progestin drospirenone provides a new contraceptive option. Ethinyl estradiol is the form of synthetic estrogen used in most oral contraceptives. Drospirenone differs from other synthetic progestins in that it is derived from 17 alpha-spirolactone and is an analogue of spironolactone. The oral contraceptive containing ethinyl estradiol and the unique progestin drospirenone has been shown to be highly efficacious and to provide safety equivalent to that of other oral contraceptive formulations.
Document emailed within 1 workday
Related Documents
Caiyan, W.; Wen, D.; Qinping, L.; Huan, S.; Ziyan, H.; Liangdan, T.; Zheng'ai, X.; Yufeng, L.; Shulan, Z.; Baihua, D.; Xiaoyan, X.; Mulan, R.; Xiaomao, L.; Youdi, X.; Zhisong, M.; Meiqing, X.; Hongyu, W.; Zirong, H. 2014: Efficacy and safety of a combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 µg in a 24+4-day regimen in China Zhonghua Fu Chan Ke Za Zhi 49(5): 355-359Caiyan, W.; Wen, D.; Qinping, L.; Huan, S.; Ziyan, H.; Liangdan, T.; Zheng'ai, X.; Yufeng, L.; Shulan, Z.; Baihua, D.; Xiaoyan, X.; Mulan, R.; Xiaomao, L.; Youdi, X.; Zhisong, M.; Meiqing, X.; Hongyu, W.; Zirong, H. 2014: Efficacy and safety of a combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 µg in a 24+4-day regimen in China Zhonghua Fu Chan Ke Za Zhi 49(5): 355-359
Mansour, D.; Verhoeven, C.; Sommer, W.; Weisberg, E.; Taneepanichskul, S.; Melis, G.B.; Sundström-Poromaa, I.; Korver, T. 2011: Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 16(6): 430-443
Oner, G.; Muderris, I.I. 2011: A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism Contraception 84(5): 508-511
Darney, P. 1993: Safety and efficacy of a triphasic oral contraceptive containing desogestrel: Results of three multicenter trials Contraception 48(4): 323-337
Kroll, R.; Ackerman, R.; Feldman, R.; Howard, B.; Weiss, H.; Hsieh, J.; Ricciotti, N. 2016: Efficacy and safety of a 21/7-active combined oral contraceptive with continuous low-dose ethinyl estradiol Contraception 93(3): 249-256
LaGuardia, K.D.; Shangold, G.; Fisher, A.; Friedman, A.; Kafrissen, M. 2003: Efficacy, safety and cycle control of five oral contraceptive regimens containing norgestimate and ethinyl estradiol Contraception 67(6): 431-437
Portman, D.J.; Kaunitz, A.M.; Howard, B.; Weiss, H.; Hsieh, J.; Ricciotti, N. 2014: Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptive Contraception 89(4): 299-306
Hadji, P.; Biskup, J.; Boekhoff, J.; Ziller, M.; Bonn, M.; Rovati, L. 2012: Evaluation of efficacy, safety and effects on symptoms of androgenization of a generic oral contraceptive containing chlormadinone acetate 2 mg/ethinylestradiol 0.03 mg Contraception 86(4): 359-365
Wiesinger, H.; Eydeler, U.; Richard, F.; Trummer, D.; Blode, H.; Rohde, B.; Diefenbach, K. 2012: Bioequivalence evaluation of a folate-supplemented oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium versus ethinylestradiol/drospirenone and levomefolate calcium alone Clinical Drug Investigation 32(10): 673-684
Klipping, C.; Duijkers, I.; Trummer, D.; Marr, J. 2008: Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen Contraception 78(1): 16-25
Zimmerman, Y.; Coelingh Bennink, H.J.T.; Wouters, W.; Ebes, F.; Fauser, B.C.J.M. 2013: The pharmacokinetics and pharmacodynamics of dehydroepiandrosterone during use of an ethinylestradiol- and drospirenone-containing oral contraceptive European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 18(6): 489-500
Fan, G.-s.; Bian, M.-l.; Cheng, L.-n.; Cao, X.-m.; Huang, Z.-r.; Han, Z.-y.; Jing, X.-p.; Li, J.; Wu, S.-y.; Xiong, C.-l.; Xiong, Z.-a.; Yue, T.-f. 2009: Efficacy and safety of drospirenone-ethinylestradiol on contraception in healthy Chinese women: a multicenter randomized controlled trial Zhonghua Fu Chan Ke Za Zhi 44(1): 38-44
Fan, G.-s.; Bian, M.-l.; Cheng, L.-n.; Cao, X.-m.; Huang, Z.-r.; Han, Z.-y.; Jing, X.-p.; Li, J.; Wu, S.-y.; Xiong, C.-l.; Xiong, Z.-a.; Yue, T.-f. 2009: Efficacy and safety of drospirenone-ethinylestradiol on contraception in healthy Chinese women: a multicenter randomized controlled trial Zhonghua Fu Chan Ke Za Zhi 44(1): 38-44
Taniguchi, F.; Enatsu, A.; Ota, I.; Toda, T.; Arata, K.; Harada, T. 2015: Effects of low dose oral contraceptive pill containing drospirenone/ethinylestradiol in patients with endometrioma European Journal of Obstetrics Gynecology and Reproductive Biology 191: 116-120
Wu, C.Q.; Grandi, S.M.; Filion, K.B.; Abenhaim, H.A.; Joseph, L.; Eisenberg, M.J. 2013: Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review Bjog: An International Journal of Obstetrics and Gynaecology 120(7): 801-810
Dickerson, V. 2002: Quality of life issues. Potential role for an oral contraceptive containing ethinyl estradiol and drospirenone Journal of Reproductive Medicine 47(11 Suppl): 985-993
Wichianpitaya, J.; Taneepanichskul, S. 2013: A comparative efficacy of low-dose combined oral contraceptives containing desogestrel and drospirenone in premenstrual symptoms Obstetrics and Gynecology International 2013: 487143
Zimmerman, Y.; Foidart, J.-M.; Pintiaux, A.; Minon, J.-M.; Fauser, B.C.J.M.; Cobey, K.; Coelingh Bennink, H.J.T. 2015: Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: I. Endocrine effects Contraception 91(2): 127-133
Szlendak-Sauer, K.; Radowicki, S.ła.; Skórzewska, K. 2009: The impact of a new low dose oral contraceptive containing drospirenone on lipid profile, carbohydrate metabolism and hepatic function Ginekologia Polska 80(2): 99-102